Brief: Corcept Therapeutics launches study on link between high cortisol and resistant hypertension
10/03/2025 14:54
March 10 (Reuters) - Corcept Therapeutics Inc CORT.O: CORCEPT THERAPEUTICS INITIATES MOMENTUM TRIAL TO DETERMINE PREVALENCE OF HYPERCORTISOLISM IN PATIENTS WITH RESISTANT HYPERTENSION Source text: nBw9cq9NLa Further company coverage: CORT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Corcept Therapeutics Incorporated
See all newsDrugmaker Corcept seeks to bar ex-judge's views in Teva antitrust case
Live Markets: US earnings forecast jumps further after key reports this week
Live Markets: Who's next for the S&P 500? The clock is ticking
U.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Corcept Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary